Actemra actpen 162 MG/0.9 ML 0.9ML

Ended Awarded Last action

Contract number
SPE2DR26FNW4G
Awardee
Awarding agency
Obligated
$25,259

Award facts

Contract value 100% obligated
$25,259.45 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $25,259.45 delivery order to AmerisourceBergen Drug Corp on March 16, 2026, for Actemra (tocilizumab) 162 mg/0.9 mL subcutaneous injection pens, with an ultimate completion date of March 17, 2026.

The order is issued under an Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999 through December 2026, which supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, Pennsylvania, the vendor's corporate office location. The delivery order carries firm fixed pricing and no set-aside designation.

Quick answers

Who was awarded contract SPE2DR26FNW4G?

SPE2DR26FNW4G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 16, 2026.

How much is contract SPE2DR26FNW4G worth?

The government has obligated $25,259 on SPE2DR26FNW4G.

Is contract SPE2DR26FNW4G an order under another contract?

Yes. SPE2DR26FNW4G is a delivery order under SPE2DR25D1021, an indefinite delivery contract.

Was contract SPE2DR26FNW4G competed?

The extent of competition for SPE2DR26FNW4G was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award